The gap between levels of care is where most plans break

If you are a parent trying to work out where a good plan goes wrong, here is the short answer: it usually goes wrong in the days between two levels of care, not inside either one of them. Treatment settings are staffed, structured, and accountable. The stretch between discharge and the first outpatient appointment is none of those things, and it is measurably where people are lost.

The gap is measured, and it is wide

The federal government tracks this. The quality measure stewarded by SAMHSA for continuity of care after inpatient or residential substance use treatment reports 2021 national medians of 30.8 percent of discharges followed by a substance use treatment service within seven days, and 37.9 percent within fourteen days (CBE #3453, Partnership for Quality Measurement).

Read that slowly. Roughly two out of three adults leaving residential or inpatient care have no recorded treatment contact in the following week. Not a poor-quality contact. No contact.

That number is not a verdict on any one program. It is a description of a system in which nobody is assigned the days between. The residential clinical team’s responsibility ends at discharge. The outpatient provider’s responsibility begins at intake. The days in between belong to the family, usually with no notice, no training, and no sleep.

Why those particular days carry so much risk

Tolerance falls during a period of abstinence. Behavior, in a hard week, does not always fall with it. That combination makes the weeks immediately after inpatient treatment the highest-risk window in the whole sequence.

A Norwegian eight-year prospective study of drug users discharged from inpatient treatment found a mortality rate ratio of 15.7 in the first four weeks after discharge compared with the rest of the follow-up period. Every death in that window was an opioid overdose (Ravndal and Amundsen, Drug and Alcohol Dependence, 2010, abstract).

That is one cohort in one country, and the absolute numbers behind the ratio are small. We cite it because the direction of the finding has been replicated repeatedly across settings that involve a period of enforced abstinence followed by an unsupervised return. The shape of the risk is consistent even where the size of it varies.

What actually helps, according to the research

The evidence on continuing care is real but it is specific, and the specificity matters more than the headline.

James McKay’s review for the NIAAA journal Alcohol Research: Current Reviews summarizes nineteen randomized trials showing a small but significant benefit for continuing care, with effect sizes of g = 0.19 at the end of the intervention and g = 0.27 at follow-up. The useful part is what separated the trials that worked from the ones that did not: longer planned duration, at least twelve months, and active effort to keep people engaged rather than a standing offer of an appointment (McKay, 2021).

So the variable is not whether aftercare was recommended on the discharge paperwork. It is whether somebody kept showing up to make it happen, for long enough that the habit outlasted the motivation.

What a family can put in place before discharge

None of this requires clinical training. It requires that the days be assigned to a person by name.

• Name who owns the first fourteen days. Not the family collectively. One person, with a phone number, who knows the whole story and does not need it re-explained.
• Book the first outpatient appointment before the discharge date, not after. If the first available slot is nineteen days out, that is your risk window, and you now know its exact length.
• Map the unstructured hours. The first Saturday, the first evening alone, the first paycheck, the first family argument. Put something in each of them on purpose.
• Write down who gets called, in what order, when something feels wrong. Before it feels wrong.
• Ask the discharging program for the actual handoff. A named contact at the next provider, a records release signed, a confirmed appointment. Not a printed list of local numbers.
• Ask about overdose risk directly, including whether naloxone should be in the house and who is trained to use it. This is a question for the clinical team, and it is a fair question to ask out loud.

Where we sit

Alongside is a non-clinical service. We do not treat, diagnose, or replace the clinical team. What we do is take ownership of the stretch that the clinical structure does not cover: the transport, the first weeks home, the standing contact, the person who is already in the car when the plan meets its first real test.

People rarely lose their footing in treatment. They lose it in the gaps between. If you are looking at a discharge date right now, the useful work is not choosing the next program. It is deciding, this week, who owns the days in between and what they are going to do with them.

If you want to think it through with a person, speak with an advisor. If you are earlier than that, Ninety days out covers the same window in more practical detail, and how we help sets out what we actually do.

Sources

• Partnership for Quality Measurement, CBE #3453, Continuity of Care After Inpatient or Residential Treatment for Substance Use Disorder (steward: SAMHSA), 2021 national medians. p4qm.org/measures/3453
• Ravndal E, Amundsen EJ. Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study. Drug and Alcohol Dependence, 2010;108(1-2):65-69. pubmed.ncbi.nlm.nih.gov/20022184
• McKay JR. Impact of continuing care on recovery from substance use disorder. Alcohol Research: Current Reviews, 2021;41(1):01. arcr.niaaa.nih.gov